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Down syndrome (DS), the main genetic cause of intellectual disability, is associated
with an imbalance of excitatory/inhibitory neurotransmitter systems. The phenotypic
assessment and pharmacotherapy interventions in DS murine models strongly
pointed out glutamatergic neurotransmission alterations (specially affecting ionotropic
glutamate receptors [iGluRs]) that might contribute to DS pathophysiology, which
is in agreement with DS condition. iGluRs play a critical role in fast-mediated
excitatory transmission, a process underlying synaptic plasticity. Neuronal plasticity
is biochemically modulated by post-translational modifications, allowing rapid
and reversible adaptation of synaptic strength. Among these modifications,
phosphorylation/dephosphorylation processes strongly dictate iGluR protein–protein
interactions, cell surface trafficking, and subsynaptic mobility. Hence, we hypothesized
that dysregulation of phosphorylation/dephosphorylation balance might affect neuronal
function, which in turn could contribute to the glutamatergic neurotransmitter alterations
observed in DS. To address this point, we biochemically purified subsynaptic
hippocampal fractions from adult Ts65Dn mice, a trisomic mouse model recapitulating
DS phenotypic alterations. Proteomic analysis showed significant alterations of the
molecular composition of subsynaptic compartments of hippocampal trisomic neurons.
Further, we characterized iGluR phosphopattern in the hippocampal glutamatergic
synapse of trisomic mice. Phosphoenrichment-coupled mass spectrometry analysis
revealed specific subsynaptic- and trisomy-associated iGluR phosphorylation signature,
concomitant with differential subsynaptic kinase and phosphatase composition of
Ts65Dn hippocampal subsynaptic compartments. Furthermore, biochemical data were
used to build up a genotype-kinome-iGluR phosphopattern matrix in the different
subsynaptic compartments. Overall, our results provide a precise profile of iGluR
phosphopattern alterations in the glutamatergic synapse of the Ts65Dn mouse model
and support their contribution to DS-associated synaptopathy. The alteration of
iGluR phosphoresidues in Ts65Dn hippocampi, together with the kinase/phosphatase
signature, identifies potential novel therapeutic targets for the treatment of glutamatergic
dysfunctions in DS.
Keywords: Down syndrome, ionotropic glutamate receptors, NMDA receptor, kinases, proteomics,
phosphoproteomics
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INTRODUCTION
Down syndrome (DS) is the most common genetic cause of
intellectual disability (OMIM #190685). Individuals with DS
present a trisomy of the human chromosome 21 (Hsa21), and
pivotal genes located in Hsa21 have been proposed as candidate
genes for DS pathophysiology (Antonarakis et al., 2004). To
model DS pathophysiology, different animal models have been
used, either overexpressing single Hsa21-homologous genes
or encompassing a partial trisomy of Hsa21 syntenic region
(Dierssen, 2012; Rueda et al., 2012). Among the latter, Ts65Dn
mouse is the most well-established DS murine model and
genetically consists of the triplication of the Hsa21 syntenic
mouse chromosome Mmu16. Ts65Dn mouse recapitulates
cognitive and motor alterations observed in individuals with
DS (Costa et al., 1999; Galdzicki and Siarey, 2003; Altafaj
et al., 2013). These alterations are neurochemically associated
with an imbalance of excitatory/inhibitory neurotransmitter
systems (Belichenko et al., 2009), similar to those described
in individuals with DS (Risser et al., 1997; Seidl et al., 2001).
This neurotransmitter imbalance resulting from the alteration
of GABAergic inhibitory neurotransmission (Fernandez et al.,
2009; Best et al., 2012; Contestabile et al., 2017), together
with excitatory glutamatergic neurotransmission defects
(Siddiqui et al., 2008; Kleschevnikov, 2012), might disturb
synaptic plasticity and impair learning and memory abilities in
Ts65Dn mice. Consequently, several attempts have been made
toward the restoration of homeostatic excitatory/inhibitory
balance. In particular, Ts65Dn treatment with memantine—a
reversible N-methyl-D-aspartate glutamate receptor (NMDAR)
antagonist—has been shown to partially rescue critical
electrophysiological alterations (Scott-McKean and Costa,
2011) and cognitive phenotypic abnormalities of trisomic
mice (Costa et al., 2007; Lockrow et al., 2011).These findings
have been significantly translated to the clinical practice,
with an improvement of the cognitive skills of individuals
with DS (Boada et al., 2012). These data strongly support the
hypothesis that Hsa21 gene overexpression (e.g., DYRK1A, APP,
TIAM1, and ITSN1 gene products) might dysregulate NMDAR
expression and/or function, contributing to DS-like pathogenesis
in trisomic mice (Siddiqui et al., 2008). NMDARs belong to
the ionotropic glutamate receptor (iGluR) family, together
with α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
receptors (AMPARs) and kainate receptors (KARs). iGluRs
importantly play a critical role in fast-mediated transmission,
a process underlying synaptic plasticity and neuronal survival
(Paoletti et al., 2013). The precise control of iGluR activity is
tuned by numerous post-translational mechanisms (Wang et al.,
2006; Traynelis et al., 2010). Among them, (de)phosphorylation
events strongly influence iGluR biogenesis (assembly, trafficking,
docking, surface diffusion, and internalization) and receptor
channel gating. These processes modulate synaptic strength
and thus modulate neuronal plasticity (Lee, 2006; Lau and
Zukin, 2007; Goebel-Goody et al., 2009; Pahl et al., 2014). The
phosphorylation pattern of iGluR results from the activity
of several canonical protein kinases (PKA, PKC, CaMKII)
(reviewed by Lussier et al., 2015) and protein phosphatases
(STEP, PP2A, PP1, calcineurin) (Westphal, 1999; Chan and
Sucher, 2001; Braithwaite et al., 2006; Sanderson et al., 2016)
that collectively modulate the gating and subcellular location
of iGluR. It has been proposed that the specific subsynaptic
location of NMDARs (synaptic vs. extrasynaptic) plays a
dichotomic role related with synaptic plasticity and neuronal
survival (Hardingham and Bading, 2010). We have recently
showed that the gene product of DS candidate gene DYRK1A
(dual-specificity tyrosine phosphorylation-regulated kinase 1)
also influences NMDAR surface expression and function similar
to NMDAR regulation by Hsa21 gene products (Grau et al.,
2014). To sum up, these data suggest that the overexpression
of Hsa21 genes impacts glutamatergic transmission in DS.
This potential functional disturbance might molecularly be
associated with and/or result from a complex reorganization of
the synaptic proteome composition and protein phosphopattern,
with protein-specific dysregulation (subsets of proteins under-
represented, over-represented, with conserved expression
and with protein and site-specific phosphorylation changes).
To identify these potential molecular changes, in this study,
we have optimized a biochemical subfractioning method
allowing the purification of subsynaptic compartments (pre-,
extra-, and postsynaptic fractions) for further proteomic and
phosphoproteomic analysis of Ts65Dn adult mice hippocampi.
Phosphoenrichment-coupled mass spectrometry analysis
revealed a subsynaptic-specific and disease-associated iGluR
phosphopattern signature. This phosphopattern is in agreement
with the concomitant subsynaptic-specific increase of kinase
expression and phosphatase downregulation in Ts65Dn mice
hippocampi. Overall, our results demonstrate an altered
phosphopattern in the glutamatergic synapse, together with
the identification of a protein kinase/phosphatase biochemical
signature in the Ts65Dn murine model, which may represent
novel therapeutic targets for DS synaptopathy.
METHODS
Mice
Ts65Dn mouse colony female B6EiC3Sn a/A-Ts(1716)65Dn
(Ts65Dn) and male B6C3F1/J mice were purchased from the
Jackson Laboratory (Bar Harbor, ME). The mouse colony was
housed and bred in the Animal Facilities of the Barcelona
Biomedical Research Park (PRBB, Barcelona, Spain, EU).
All animal procedures met the guidelines of the European
Community Directive 86/609/EEC and were approved by
the Local Ethics Committee. The mice were housed under a
12:12 h light–dark schedule (lights on at 8:00 a.m.) in controlled
environmental conditions of humidity (60%) and temperature
(22 ± 2◦C) with food and water ad libitum. Both Ts65Dn
and euploid mice were genotyped by qPCR, following the
Jackson laboratories protocol (https://www.jax.org/research-
and-faculty/tools/cytogenetic-and-down-syndrome-models-
resource/protocols/cytogenic-qpcr-protocol).
Antibodies
Antibodies were obtained from commercial suppliers as it
follows: anti-PSD95 (Neuromab, #P78352), anti-synaptophysin
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(Sigma-Aldrich, S5768), anti-β-actin (Sigma-Aldrich, A5316),
anti-GluN2A (Sigma-Aldrich, M264), anti-GluN1 (Millipore,
#AB9864R), anti-CaMKIIα (CST, #50049), anti-Fyn (CST,
#4023), anti-pS890 GluN1 (CST, #3381), anti-pS1284 GluN2B
(CST, #5355), anti-rabbit IgG-horseradish peroxidase (HRP;
Dako, #P0448), and anti-mouse IgG-HRP (Dako, # P0447).
Subsynaptic Fractionation and Western
Blot
Subsynaptic fractionation protocol was adapted from the
protocol developed by Philips and collaborators (Phillips et al.,
2001). This protocol allows the obtention of the enriched
extrasynaptic (Extra), postsynaptic (Post), and presynaptic (Pre)
fractions from brain regions. In brief, the frozen tissue was
thawed in cold buffer A (50mM Tris-HCl pH 7.4, 0.32M
sucrose, 5mM EDTA, 1mM EGTA, 1µg/ml aprotinin, 1µg/ml
leupeptin, 1/2500 PMSF, 20µM ZnCl2, 50mM NaF, 1mM
sodium orthovanadate, 2.5mM sodium pyrophosphate, and
a cocktail of protease inhibitors [Complete, Roche]) and
mechanically homogenized using a potter. The homogenate
was centrifuged for 10min at 1,400 g, and the supernatant was
collected. To increase the yield of protein recovery, this step
was repeated thrice. The collected supernatants were pooled
and centrifuged for 10min at 700 g. The resulting supernatant
was again centrifuged for 15min at 21,000 g. The resultant
pellet containing the crude membrane fraction was kept for
further subfractionation, as follows. Crude membrane fraction
was solubilized in buffer B (0.32M sucrose, 50mM Tris-HCl,
pH 7.4) and loaded on a discontinuous sucrose step gradient
(0.85M/1.0 M/1.2M). Further after centrifugation at 82,500 g for
2 h, the synaptosomes (Syns) were collected from the 1.0M/1.2M
interface and diluted in 50mM Tris-HCl pH 7.4 and centrifuged
once more for additional 30min at 21,000 g. Then this pellet
was collected and resuspended in synaptosomal resuspension
buffer, consisting of 36mM sucrose 0.1mM CaCl2 + 10mM
NaF + 1mM sodium orthovanadate, 2mM EDTA, protease,
and phosphatase inhibitor cocktail (HaltTM, ThermoFisher),
leading to the purified synaptosomal fraction (P2) for further
subsynaptic fractionation, as follows. In brief, synaptosomes
were solubilized by resuspending in 40mM Tris-HCl pH 6.0
containing 1% triton X-100 and incubated at 4◦C for 30min
under agitation. Following centrifugation at 40,000 g for 30min,
the supernatant fraction (corresponding to the extrasynaptic
fraction) was acetone precipitated. The pellet, containing the
synaptosomal junction, was resuspended in 20mM Tris-HCl
buffer pH 8.0 supplemented with 1% triton X-100. After 30-min
incubation at 4◦C, the fractions were separated by centrifugation
at 40,000 g for 30min. The resulting supernatant, corresponding
to the enriched presynaptic fraction, was acetone precipitated.
The pellet, containing the enriched postsynaptic fraction, was
resuspended in 50mM Tris buffer—2% SDS, as well as the
resulting acetone-precipitated subsynaptic fractions.
For western blot analysis, equal protein amounts from
each sample were loaded and separated using 8 and 10%
SDS-PAGE. The proteins were transferred onto nitrocellulose
membranes (Invitrogen) using iBlot semi-dry blotting system
(Life Technologies). After transient staining of transferred
proteins by Ponceau S staining, the membranes were blocked
with 10% skim milk in TBST (10mM Tris-HCl, 100mM
NaCl, 0.1% Tween-20) for 1 h. The membranes were incubated
overnight at 4◦C with the corresponding primary antibodies
(diluted in TBST/+5% skimmed milk) and followed by
incubation with HRP-conjugated anti-mouse, anti-guinea pig
IgG-HRP, or anti-rabbit IgG secondary antibodies (Dako)
for 1 h at room temperature. The detection was performed
with chemiluminescence using Amersham ECL Prime Western
blotting detection reagent (GE, Amersham) according to
the manufacturers’ instructions. The immunoreactive bands
were visualized using a ChemiDoc MP (BioRad), and the
immunoreactive signals were analyzed using the Image Lab
Biorad software.
Nano-UPLC Mass Spectrometry System
and Phosphopeptide Enrichment
Mass spectrometry experiments were performed from two
independent biological replicates. Each replicate consisted of
a pool of hippocampi (N = 4 mice/genotype) that were
subsequently fractionated to obtain subsynaptic fractions, either
from euploid or from trisomic mice. Following resuspension
and protein quantification, subsynaptic fractions (70–200 µg)
were diluted in 1% SDS and digested with the single sequence-
specific protease trypsin, following the previously described
FASP protocol (Wis´niewski et al., 2009). Digested peptides
were subjected to phosphopeptide enrichment using the
High-SelectTM TiO2 Phosphopeptide Enrichment Kit (Thermo
Fisher Scientific). About 45% of each enriched sample was
analyzed using an Orbitrap Fusion Lumos with an EASY-Spray
nanosource coupled to a nano-UPLC system (EASY-nanoLC
1000 liquid chromatograph) equipped with a 50-cm C18 column
(EASY-Spray; 75µm id, PepMap RSLC C18, 2-µm particles,
45◦C). Chromatographic gradients started at 5% buffer B with a
flow rate of 300 nl/min and gradually increased to 22% buffer B
in 79min and to 32% in 11min. After each analysis, the column
was washed for 10min with 95% buffer B (buffer A: 0.1% formic
acid in water and buffer B: 0.1% formic acid in acetonitrile). The
mass spectrometer was operated in data-dependent acquisition
mode, with full MS scans over a mass range ofm/z 350–1500 with
detection in the Orbitrap (120-K resolution) and with auto gain
control (AGC) set to 100,000. In each cycle of data-dependent
acquisition analysis, following each survey scan, the most intense
ions above a threshold ion count of 10,000 were selected for
fragmentation with HCD at normalized collision energy of 28%.
The number of selected precursor ions for fragmentation was
determined by the “Top Speed” acquisition algorithm (maximum
cycle time of 3 s), and a dynamic exclusion of 60 s was set.
Fragment ion spectra were acquired in the ion trap with an AGC
of 10,000 and a maximum injection time of 200ms.
Raw Data Processing and Data Analysis
Acquired data were analyzed using the Proteome Discoverer
software suite (v2.0, Thermo Fisher Scientific), and the Mascot
search engine (v2.5.1, Matrix Science) was used for peptide
identification. Data were searched against a Mus musculus
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protein database derived from SwissProt and included the most
common contaminants. A precursor ion mass tolerance of 7 ppm
at the MS1 level was used, and up to three missed cleavages for
trypsin were allowed. The fragment ion mass tolerance was set to
0.5 Da oxidation of methionine; N-terminal protein acetylation
and phosphorylation in serine, threonine, and tyrosine were
defined as variable modification; and carbamidomethylation of
cysteines was set as fixed modification. The identified peptides
were filtered by 5%FDR, and only those proteins identified in
both biological replicates (for each condition) were retained for
further analysis (Supplementary Table 1).
Bioinformatic Analysis of Proteomic Data
The proteomic signature of the experimental groups was
represented using Venn diagrams. These diagrams were created
using VENNY 2.1 freeware (http://bioinfogp.cnb.csic.es/tools/
venny/; Oliveros et al., 2007–2015). This graphical interface
allowed the representation of proteins overlapped among groups,
together with the visualization of differentially expressed proteins
in the different groups/fractions.
To functionally classify the differentially expressed proteins
from the different groups (subsynaptic fraction and genotype),
the data were submitted to the Database for Annotation,
Visualization, and Integrated Discovery (DAVID: http://david.
abcc.ncifcrf.gov/). This software, based on the use of gene
ontology (GO), was used for grouping the differentially expressed
proteins into biological processes, molecular functions, and
cellular components.
In Silico Analysis of Phosphoproteomic
Data
An updated database of murine kinases and phosphatases was
generated before the analysis of the phosphoproteomic data. To
this end, Uniprot database was used as the reference library,
proteins were sorted (e.g., “kinase” and “phosphatase” criteria),
and the protein list was further manually curated. This database
was used to analyze potentially differentially expressed kinases
and phosphatases between genotypes (Supplementary Table 2).
The analysis of the proteome and phosphoproteome
signatures was performed using, as inclusion criteria, the
identification of the proteins and phosphosites in both biological
replicates. Furthermore, the conserved phosphosites were
classified based on their qualitative expression in the different
subsynaptic compartments, as well as in their relative expression
levels. Regarding the latter, proteins and phosphosites detected in
both fractions were classified based on the relative TS:EU ratio,
resulting from the mean MS peak area (TS) (replicates 1 and
2)/mean MS peak area (EU) (replicates 1 and 2). Ratios <0.75 or
>1.5 were considered as downregulated and upregulated protein
levels, respectively (see Supplementary Table 3).
Following phosphoproteomic profile identification of
trisomic subsynaptic fractions, a systems biology approach was
conducted to infer the potential kinases associated with the
phosphoproteomic profile. To this end, the Human protein
Reference Database (Hprd.org) was used, and the putative
kinases involved in the phosphoprofile were identified. Finally,
an interaction network analysis was performed using the Search
Tool for the Retrieval of Interacting Genes/Proteins database
(STRING; http://www.string-db.org/). This bioinformatic tool
allowed the generation of protein–protein interaction networks,
integrating the kinases/phosphatases and iGluR phosphoprofile
of Ts65Dn subsynaptic fractions.
Statistical Analysis
Comparison of immunolabeling signal intensities between
euploid and trisomic hippocampal fractions was evaluated using
the GraphPad software. All datasets passed the Kolmogorov–
Smirnov normality test and were analyzed applying a two-tailed
unpaired t-test with Welch’s correction. Graph bars represent the
mean± SEM for each group.
RESULTS
Subsynaptic Proteomic Signature of the
Ts65Dn Mice Hippocampi
Neuronal communication mainly resides in the synapse, a highly
specialized subcellular compartment juxtaposing crosstalking
neurons. Within synapses, there is an additional morphological
compartmentalization that allows the precise neurotransmitter
and structural machinery positioning, underlying neuronal
function. Consequently, potential specific changes on protein
composition of the subsynaptic compartments can impact
synaptic function and ultimately alter Ts65Dn glutamatergic
neurons. To address this issue, we performed a subsynaptic
fractionation protocol toward the obtention of extrasynaptic-,
presynaptic-, and postsynaptic-enriched hippocampal fractions,
both from euploid and from trisomic adult mice (Figure 1A).
Hippocampal subsynaptic fractionation protocol was
validated by western blot, using specific subsynaptic
compartment markers. As expected, extrasynaptic fraction
showed an elevated signal of synaptophysin, whereas the
postsynaptic fraction was enriched in scaffolding protein PSD95
(Figure 1A). Moreover, we observed a significant enrichment
of the NMDA receptor subunits GluN1 and GluN2A in the
postsynaptic fraction (Figure 1A). Overall, these biochemical
studies confirmed the obtention of enriched subsynaptic
compartments from murine brain tissue, and the same protocol
was used to obtain enriched subsynaptic hippocampal fractions
for mass spectrometry analysis.
Subsynaptic fractions (postsynaptic and extrasynaptic)
were subjected to trypsin digestion, and mass spectrometry
studies were performed. Data analysis was based on the
comparison of the genotype effect on the subsynaptic
proteomic/phosphoproteomic signature (defined as the
overlapping profile of the biological replicates).
Proteomic analysis allowed the identification of 1922 proteins
(M.musculus protein database, SwissProt) consistently present in
both biological replicates (Figure 1B). Subsynaptic distribution
analysis of these proteins showed that 938/1043 proteins are
present in the postsynaptic fraction of euploid/trisomic mice,
respectively, whereas 863/1059 proteins are present in the
extrasynaptic fractions of euploid/trisomic mice, respectively
(Figure 1C and Supplementary Table 1). Despite the proteomic
profile showed the presence of conserved proteins in trisomic
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FIGURE 1 | Subsynaptic fractionation and proteomic analysis of Ts65Dn mouse hippocampus. (A) Experimental workflow followed for hippocampal subsynaptic
fractions obtention and mass spectrometry phosphoproteomic studies (mass spectra of biological replicates 1 and 2 are figurative representations). Down left panel,
Representative western blot analysis of adult hippocampal subsynaptic fractions. Antibodies directed against PSD95 and synaptophysin were used as markers of
postsynaptic and extrasynaptic, respectively. Right up panel, Western blot analysis of NMDAR subunits GluN2A and GluN1 in subsynaptic fractions (Post,
postsynaptic; Extra, extrasynaptic) of adult euploid (EU) and trisomic (TS) mice. (B) Venn’s diagram representing total identified proteins overlap between biological
replicates 1 and 2 (postsynaptic and extrasynaptic fractions from both genotypes). (C) Venn’s diagram representing genotype (EU, euploid; TS, trisomic) and
subsynaptic compartment (Post, postsynaptic; Extra, extrasynaptic) effect on protein composition.
hippocampal synapses (60.7 and 57.8% protein coincidence
for postsynaptic and extrasynaptic fractions, respectively;
Figures 2A, 3A), significant protein composition changes were
detected in trisomic hippocampi. Further in silico analyses were
performed to analyze the potential functional outcomes of these
proteomic changes.
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FIGURE 2 | Gene ontology analysis of Ts65Dn mouse hippocampal postsynaptic proteome. (A) Venn’s diagram representing comparative protein composition
between postsynaptic fractions of adult euploid (EU) and Ts65Dn (TS) hippocampi. The diagram represents proteins detected in euploid replicates (blue circle), in
trisomic replicates (yellow circle), and commonly detected in replicates from euploid and trisomic samples (white circle). (B–E) Functional annotation analysis of
proteins enriched in hippocampal postsynaptic fractions of euploid (B,D) and trisomic (C,E) hippocampi (B,C). Bar graphs representing top five significantly enriched
GO terms, based on “cellular compartment” criteria (D,E). Table listing top five significantly enriched proteins related with “biological process” and “molecular function”
GO terms, in the postsynaptic fraction of euploid (D) and trisomic (E) hippocampi.
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FIGURE 3 | Gene ontology analysis of Ts65Dn mouse hippocampal extrasynaptic proteome. (A) Venn’s diagram representing comparative protein composition
between extrasynaptic fractions of adult euploid (EU) and Ts65Dn (TS) hippocampi. The diagram represents proteins detected in euploid replicates (green circle), in
trisomic replicates (red circle), and commonly detected in replicates from euploid and trisomic samples (white circle). (B–E) Functional annotation analysis of proteins
enriched in hippocampal extrasynaptic fractions of euploid (B) and trisomic (C) hippocampi (B,C). Bar graphs representing top five significantly enriched GO terms,
based on “cellular compartment” criteria (D,E). Table listing top five significantly enriched proteins related with “biological process” and “molecular function” GO terms,
in the extrasynaptic fraction of euploid (D) and trisomic (E) hippocampi.
Gene Ontology Enrichment Analysis of
Subsynaptic Ts65Dn Proteomic Signature
The genotype effect on protein composition of the postsynaptic
and extrasynaptic fractions was performed following the
GO-term-based protein enrichment analysis. For functional
annotation studies, only those proteins showing differential
subsynaptic fraction expression were considered (Figures 2A,
3A). Statistical enrichment analysis of “cellular compartment,”
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FIGURE 4 | Kinome and kinase-iGluR interactome analysis of Ts65Dn mouse hippocampal postsynaptic fraction. (Top) Venn’s diagram representing comparative
analysis of protein kinases expressed in the postsynaptic fraction of adult euploid (EU) and Ts65Dn (TS) mice. The diagram represents proteins detected in euploid
replicates (blue circle), in trisomic replicates (yellow circle), and commonly detected in replicates of euploid and trisomic samples (purple circle). The diagram shows
the number of kinases not detected/underrepresented in Ts65Dn mice (in red), with similar expression (TS:EU expression ratio = 0.75–1.25; black characters) and
present/overrepresented in trisomic mice (in green). (Bottom) Protein–protein interaction (PPI) network of protein kinases, scaffolding proteins, and iGluRs
(Continued)
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FIGURE 4 | upregulated in Ts65Dn postsynaptic fraction. Node color annotation: red, kinase activity; blue, postsynaptic density-associated kinase; green,
participation in long-term potentiation; and yellow, present in the glutamatergic synapse; link color annotation: known interactions (light blue: curated databases; pink:
experimentally determined), predicted interactions (green: gene neighborhood; red: gene fusions; blue: gene co-occurrence), and others (light green: text mining;
black: coexpression; purple: protein homology).
“biological processes,” and “molecular functions” revealed
the presence of significant genotype-dependent differences,
both in the postsynaptic and in the extrasynaptic fractions
(Figures 2B–E, 3B–E).
GO-term analysis of the euploid-specific postsynaptic
proteome indicated the presence of an enriched representation
of dendrite-associated proteins, thereby reflecting a dendritic
protein under-representation in the trisomic postsynaptic
fraction (Figures 2B–D). Moreover, GO analysis of the trisomic
postsynaptic fraction showed significant changes in the following
cellular functions: membranes, cytoplasm, transport, and protein
binding (Figures 2C–E).
Regarding the extrasynaptic fractions, GO-term analysis
of the euploid-specific extrasynaptic fraction showed the
presence of mitochondria and protein phosphatase-binding
proteins, indicating their relative absent detection in the
trisomic extrasynaptic fraction (Figures 3B–D). In contrast, GO
analysis of trisomic extrasynaptic fraction indicated changes
in membrane, cytoplasm, synapse transport, phosphorylation,
protein kinase activity, and protein binding (Figure 3C–E).
Overall, GO-term analysis suggested that the subsynaptic
proteome of the trisomic hippocampus is altered, in terms of both
cellular compartments and functional outcomes. In particular,
the analysis strongly suggested that phosphorylation-associated
processes could be affected, as described below.
Altered Expression of Kinases and
Phosphatases in the Ts65Dn Mouse
Hippocampal Subsynaptic Fractions
Based on the functional annotation analyses showing alterations
in phosphorylation, protein kinase activity, and phosphatase
binding in the Ts65Dn synapses, we aimed to elucidate potential
expression changes in kinases and phosphatases. To this end,
an updated mouse kinome and phosphatome database was
developed, using Uniprot as the reference database and filtering
the M. musculus protein entries for the extraction of mouse
kinases and phosphatases (Supplementary Table 2). Afterward,
the genotype effect was compared either for postynaptic or
for extrasynaptic fractions. With respect to euploid mice, the
postsynaptic fraction of trisomic mice showed the presence of
a subset of specific/enriched kinases and phosphatases (50 and
10 proteins, respectively), together with nondetectable/reduced
expression of kinases and phosphatases (21 and 7 proteins,
respectively) (Figure 4 and Supplementary Figure 1A). The
comparative study of the extrasynaptic fractions indicated the
presence, in trisomic samples, of a subset of specific/enriched
kinases and phosphatases (37 and 7 proteins, respectively),
together with non-detectable/reduced expression of kinases and
phosphatases that are present in euploid samples (five and
eight proteins, respectively) (Figure 5 and Supplementary Figure
1B). We performed western blot analysis of MS-identified
kinases with putative differential expression to validate these
unbiased findings. In agreement with proteomic data, western
blot showed a significant increase of CamKII expression levels
in the postsynaptic fraction of trisomic mice (p = 0.033, two-
tailed Student’s t-test), together with a significant decrease of Fyn
kinase levels in the postsynaptic and a concomitant increase in
the extrasynaptic fraction of the Ts65Dn mice (p = 0.015 and
0.024, respectively; two-tailed Student’s t-test; Supplementary
Figure 2A).
Further, we aimed to predict the potential consequences
of the dysregulated trisomic synaptic kinome. We focused
in silico analysis on the ionotropic family of glutamate
receptors similar to the glutamatergic alterations reported in the
Ts65Dn mouse model. The potential protein–protein interaction
networks between iGluRs and protein kinases upregulated in
the trisomic fractions (either postsynaptic or extrasynaptic)
were analyzed using STRING software. Interactome analysis of
the trisomic postsynaptic fraction unraveled significant kinase-
iGluR interaction, as shown by the elevated number of edges
(predicted number of edges: 123 vs. expected number of edges:
18) and the PPI enrichment (p-value = 0), indicating the
significant interactions within the PPI network. In particular,
STRING analysis identified protein kinases from the CaMKII
family, Dlgap1, Agap2, MRCKβ distinctively interacting with the
detected iGluR subunits (GluN1, GluN2A, GluN2B, GluN2D,
GluA1, and GluA2; Figure 4). Interactome analysis of the
trisomic extrasynaptic fraction unraveled significant kinase-
iGluR interaction, as shown by the significant increase of the
network edges (predicted number of edges: 51 vs. expected
number of edges: 21) and the PPI enrichment (p-value =
2.49.10–8), indicating the significant interactions of the PPI
network. Moreover, several kinases (CaMKII kinase family
members, cAMP-dependent protein kinase, PKC family, and
Agap2) distinctively interacting with GriA1 and GriA2 subunits
of the AMPARs were also significantly detected (Figure 5).
Altered iGluR Subsynaptic Phosphopattern
in the Ts65Dn Mouse Hippocampus
Hippocampal subsynaptic fractions were analyzed by
phosphoenrichment-coupled mass spectrometry to evaluate
the predictive kinome-iGluR interactome model. The
phosphoproteome of the different fractions was analyzed, and
a total of 59 iGluR phosphosites were identified in the different
biological replicates (Supplementary Table 3). From these, only
those iGluR phosphosites found in both replicates were retained
for further genotype effect analysis (Figure 6 and Supplementary
Table 3). This technique allowed the identification of several
iGluR phosphosites, mostly corresponding to previously
reported phosphoresidues (15 individual phosphosites); two
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FIGURE 5 | Kinome and interactome kinase-iGluR analysis of hippocampal extrasynaptic fraction of Ts65Dn mice. (Top) Venn’s diagram representing comparative
analysis of protein kinases expressed in the extrasynaptic fraction of adult euploid (EU) and Ts65Dn (TS) mice. The diagram represents proteins detected in euploid
(Continued)
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FIGURE 5 | replicates (green circle), in trisomic replicates (red circle), and commonly detected in replicates of euploid and trisomic samples (dark green circle). The
diagram shows the number of kinases not detected/underrepresented in Ts65Dn mice (in red), with similar expression (TS:EU expression ratio = 0.75–1.25; black
characters) and present/overrepresented in trisomic mice (in green). (Bottom) Protein–protein interaction (PPI) network of protein kinases and iGluRs upregulated in
Ts65Dn extrasynaptic fraction. Node color annotation: red, kinase activity; blue, postsynaptic density-associated kinase; green, participation in long-term potentiation;
and yellow, present in the glutamatergic synapse; link color annotation: known interactions (light blue: curated databases; pink: experimentally determined), predicted
interactions (green: gene neighborhood; red: gene fusions; blue: gene co-occurrence), and others (light green: text mining; black: coexpression; purple: protein
homology).
FIGURE 6 | Phosphopattern profile of NMDA and AMPA receptor subunits in the adult Ts65Dn mouse hippocampus. (A–D) Schematic representation of
phosphoproteome-identified phosphosites on NMDAR subunits (GluN1 and GluN2A and GluN2B) and AMPAR subunit GluA1, in adult hippocampal subsynaptic
fractions. The phosphoresidue position is indicated, together with the presence and/or relative phosphorylation of trisomic:euploid MS peak (black: phosphosite
present in euploid and trisomic samples; light green: increased levels detected in trisomic fractions; dark green: phosphosites exclusively detected in trisomic
samples). (E) Table listing iGluR phosphosites identified in euploid and/or trisomic hippocampal fractions, together with the predicted phosphorylating kinases.
Phosphosites previously reported in (1) Munton et al. (2007), (2) Lundby et al. (2012), (3) Li et al. (2016), (4) Maki et al. (2013), (5) Trinidad et al. (2012), (6) Zhang et al.
(2013), (7) Wis´niewski et al. (2010) and (8) McQueen et al. (2017).
novel phosphosites were identified. Importantly, the subsynaptic
iGluR phosphopattern was characterized in the hippocampus
of Ts65Dn mice. Using this unbiased method, the identified
upregulated phosphosites (displaying higher MS peaks in
trisomic samples) showed an elevated representation of NMDAR
subunits (eight phosphosites for GluN2A, seven for GluN2B,
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and one for GluN1), whereas only one phosphosite was detected
in GluA1 subunit (AMPAR subunit) and no phosphosites
were identified in KAR subunits. We performed western blot
analysis on selected MS-identified differentially expressed
phosphosites to further validate our results. This analysis
showed an increase of both GluN1(pS890) and GluN2B(pS1284)
levels in the postsynaptic fraction of trisomic mice, although
not significant, in agreement with the changes observed
along unbiased phosphoproteomic analysis (Supplementary
Figure 2B). Finally, the kinases putatively phosphorylating
the consensus iGluR phosphoresidues were in silico predicted
using “Phosphomotif Finder” software. This analysis predicted
a potential enzymatic activity of CaMKII, PKC, CK1 on the
identified iGluR phosphoresidues, which would be in agreement
with their above mentioned upregulated expression.
DISCUSSION
In the present study, we have performed a phosphoenrichment-
coupled mass spectrometry analysis that showed altered
functional changes in the hippocampal extrasynaptic and
postsynaptic fractions of the Ts65Dn mice, a trisomic mouse
model recapitulating DS phenotypic alterations. The majority
of kinases interacting with iGluRs remarkably show an overall
increase in trisomic samples, whereas the majority of iGluR-
related phosphatases show reduction, with some exceptions
in both protein categories. These results are concomitant with
the increased number of iGluR phosphopeptides identified by
the phosphoproteomic analysis of Ts65Dn mice hippocampal
postsynaptic fractions. Importantly, in silico kinome-iGluR
phosphopattern analysis supported the role of specific kinases
and their potential iGluR phosphosites in the neuronal
pathophysiology of Ts65Dn mouse.
The initial proteome analysis showed a relative conservation
of the number of proteins (roughly 1,000 proteins identified),
regardless of the subsynaptic fraction and genotype. The
comparative study of the genotype effect on the subsynaptic
fraction composition showed a protein coincidence of 60.7
and 57.8% for the postsynaptic and extrasynaptic fractions,
respectively. This quantitative analysis indicates a different
molecular composition of the Ts65Dn hippocampal synapses,
which might result from the overexpression of triplicated
genes. Hence, several proteins are differentially expressed in
the subsynaptic compartments of Ts65Dn hippocampal neurons,
potentially reflecting the molecular substrates associated with
Ts65Dn synaptic abnormalities. Interestingly, further GO-
term-based protein enrichment analysis supported functional
outcomes of the proteomic changes detected in the postsynaptic
and extrasynaptic fractions of trisomic mice. In particular, the
postsynaptic fraction of trisomic mice showed a relative decrease
of proteins related with “dendritic function” GO term. This
finding is in agreement with previous studies showing a reduction
of dendritic branching and spine density in Ts65Dn mice
(Belichenko et al., 2007) which, in the context of individuals with
DS, might recapitulate the dendritic deterioration reported in DS
fetal brains (Weitzdoerfer et al., 2001). Moreover, GO analysis
revealed a differential enrichment of structural synaptic proteins
within the extrasynaptic compartment. In particular, the trisomic
extrasynaptic compartment showed a significant enrichment of
GO-term “synapse.” Further analysis showed the presence of
Homer3, one of the most abundant scaffolding proteins of the
postsynaptic density in euploid mice (Hayashi et al., 2009), in
extrasynaptic fractions of trisomic mice. These data, together
with previous electron microscopy studies showing the presence
of enlarged spines in Ts65Dn neurons (Belichenko, 2004;
Benavides-Piccione et al., 2004), suggest that the morphological
alterations of Ts65Dn spines might be associated with a disrupted
protein composition of the extrasynaptic fraction. Interestingly,
GO-term enriched analysis also showed a significant reduction of
mitochondrial proteins in the extrasynaptic fraction of trisomic
mice. This finding is in line with previous studies reporting
a reduction of mitochondrial complexes and redox activity in
neuronal cultures andDS fetuses, leading to severemitochondrial
dysfunctions that can affect synaptic metabolism, energy, and
function (Izzo et al., 2014).
Besides the differential enrichment of structure- and
energy-associated proteins, a significant alteration of
phosphorylation-associated proteins was detected in the
trisomic subsynaptic compartments. Indeed, the extrasynaptic
trisomic fraction showed an enrichment of “protein
phosphorylation” and “protein kinase activity” GO terms,
while “protein phosphatase binding” (enriched in euploid
extrasynaptic fraction) was significantly reduced. Although these
evidences were suggestive of an altered enzymatic activity of
kinases/phosphatases in Ts65Dn hippocampi, a more detailed
analysis of kinase/phosphatase subsynaptic expression levels
was performed. This analysis roughly showed an increase of
kinase expression, together with a reduction of phosphatase
levels in the Ts65Dn mouse model. In our study, further detailed
analysis of the trisomic kinome showed increased levels of
CaMKII subunits (alpha, beta, delta, and gamma subunits) in
hippocampal postsynaptic and extrasynaptic fractions of Ts65Dn
mice, by proteomics and WB techniques. This increase could
result in an enhanced CamKII activity, similar to previous
studies showing increased phosphorylated CaMKII in Ts65Dn
hippocampi (Siarey et al., 2006). In agreement with this kinase
increase, previous work of Fernandez and collaborators showed
an increased amount of phosphopeptides in crude synaptosomes
from Ts65Dn mice (Fernandez et al., 2009). Overall, our
proteomic data and the previously cited morphological studies
support the relationship between biochemical alterations and
structural changes of the trisomic hippocampal neurons. These
morphological and biochemical alterations can result in a
subsynaptic mislocalization of proteins, potentially affecting
synaptic shape, changing the postsynaptic density molecular
composition, and ultimately the function synaptic activity of
trisomic neurons. In summary, these results strengthen the
hypothesis that morphological and functional dendritic/synaptic
abnormalities, such as those detected in our study, may directly
impact synaptic plasticity (Cramer and Galdzicki, 2012) and lead
to cognitive impairment.
Interactome analysis revealed significant interactions between
protein kinases enriched in trisomic subsynaptic fractions and
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iGluR subunits. In the postsynaptic fraction, these kinases
interact with both NMDAR and AMPAR subunits. In contrast,
the interactome analysis only revealed potential protein–
protein interactions of these kinases with GluA1 and GluA2
subunits of the AMPAR, which are proportionally more largely
represented than NMDAR subunits in the extrasynaptic fraction.
Following this predictive analysis, we performed an accurate
characterization of the iGluR phosphopattern in hippocampal
subsynaptic fractions of Ts65Dn mice. Further bioinformatic
analyses were focused on the phosphorylation of these receptors
to unveil potential changes on iGluR phosphopattern. In
sample preparation, the fractions followed tryptic digestion
with a single protease (trypsin) for further unbiased MS
method. Technically, the use of a single protease limited the
extent of detectable phosphopeptides (Dephoure et al., 2013).
Moreover, the reported low abundance of phosphopeptides
(Parker et al., 2010) might also contribute to underestimate the
complete phosphoproteome of trisomic hippocampal synapses.
Despite these intrinsic technical limitations, a total amount
of 17 individual iGluR phosphosites were identified in our
study, 15 of them corresponding to previously reported
phosphosites (PhosphositePlus, Cell Signaling Technology Inc.)
(Lussier et al., 2015) (Figure 6E). In the past, Siarey and
collaborators showed increased phosphorylation levels of iGluR
phosphosites in Ts65Dn mice, such as GluA1(pS831) (Siarey
et al., 2006). In line with these, our results showed an over-
representation of iGluR phosphoresidues in specific Ts65Dn
synaptic compartments identified, supporting the hypothesis
that iGluR phosphopattern is associated with the synaptic
transmission and glutamatergic dysfunctions reported in the
Ts65Dnmouse model of DS. Furthermore, iGluR phosphoprofile
analysis provided potential functional links between increased
levels of iGluR sububnits in Ts65Dn synaptic fractions and in
silico predicted kinases phosphorylating those phosphoresidues.
This group of candidate kinases contained CaMKII, PKC, and
CK1, previously described as iGluR regulatory kinases (Lan
et al., 2001; Chergui, 2005; Sanz-Clemente et al., 2013; Lussier
et al., 2015). Our proteomic study significantly showed an
upregulation of these kinases in trisomic hippocampi, supporting
the association between their overexpression and the changes on
iGluR phosphopattern. Regarding the latter, a significant elevated
representation of GluN2A and GluN2B subunit phosphopeptide
was detected in trisomic postsynaptic fractions. This biochemical
signature suggests a relevant contribution of abnormally
phosphorylated GluN2A- and GluN2B-containing NMDARs in
Ts65Dn phenotype. Indeed, our group and others have previously
provided biochemical and pharmacological evidences supporting
the role of NMDAR alterations in the DS murine models
(Costa et al., 2007; Altafaj et al., 2008; Hanson et al., 2013;
Grau et al., 2014). It has been reported that, specifically, CA3-
CA1 hippocampal LTP is functionally reduced in Ts65Dn mice
(Siarey et al., 2006). Moreover, trisomic mice exhibit an increased
NMDAR-dependent LTD that can be pharmacologically rescued
with memantine, an NMDAR antagonist (Scott-McKean and
Costa, 2011). The alterations on NMDAR activity observed
in Ts65Dn mice might probably be influenced by changes
in NMDAR expression levels and/or the NMDAR (and other
iGluR) phosphopattern signature described in the present
study. Likewise, our previous studies showed that in the
TgDyrk1A transgenic mouse model, DYRK1A overexpression
is associated with GluN2A subunit upregulation (Altafaj
et al., 2008). This increased density mechanistically results
from a Dyrk1A-mediated phosphorylation of GluN2A subunit
(GluN2A(pS1048)) that reduces NMDAR internalization and
functionally increases NMDAR-mediated currents and modifies
NMDAR gating properties (Grau et al., 2014). Unfortunately,
the methodology followed in this study (trypsin digestion) was
not compatible with GluN2A(pS1048) detection. Although our
study revealed Dyrk1A presence in the hippocampal postsynaptic
fraction and previous studies showed DYRK1A overexpression
in DS, our data suggest that Dyrk1a-mediated phosphorylation
GluN2A(pS1048) might contribute to DS synaptic alterations, a
hypothesis that might be explored in the future. Interestingly,
several iGluR phosphosites identified in this study have been
associated with synaptic plasticity mechanisms. Among these,
GluN1(pS890) has been showed to disturb GluN1 surface clusters
(Tingley et al., 1997), and GluN2A(pS929) phosphorylation
has been described as modulating GluN2A subunit containing
NMDAR desensitization (Maki et al., 2013). Regarding GluN2B
subunit phosphorylation, GluN2B(pS1303) phosphorylation
has been shown to increase GluN1/GluN2B currents (Liao
et al., 2001), and GluN2B(pS1116) phosphorylation potentiates
NMDAR currents and Ca2+ permeability (Murphy et al., 2014).
Overall, the presence of discrete NMDAR phosphosites with
relevant function in synaptic function and the identification of
their relative overrepresentation in trisomic mice support the
contribution of glutamatergic neurotransmission alterations in
Ts65Dn mice phenotype.
Furthermore, some of the phosphosites found to be over-
represented in our study had previously been described
to be involved in synaptic plasticity. For example, GluN1
S890 phosphorylation disperses the surface clusters of
GluN1 (Tingley et al., 1997). GluN2A S929 phosphorylation
modulates desensitization of GluN2A/NMDA receptors
(Maki et al., 2013). GluN2B S1303 phosphorylation increases
GluN1/GluN2B currents (Liao et al., 2001). GluN2B S1116
phosphorylation potentiates the receptor currents and its
permeability to Ca2+ (Murphy et al., 2014). Consequently,
their upregulation could lead to alterations in synaptic
plasticity. Overall these findings suggest that the altered
kinome and iGluR phosphopattern (mainly affecting GluN2A
and GluN2B subunits) can contribute to the glutamatergic
neurotransmission dysfunctions present in the Ts65Dn mouse
model of DS.
In summary, our study revealed an altered subsynaptic
composition of the adult Ts65Dn mouse hippocampus. These
molecular subsynaptic alterations might functionally be
underlying the Ts65Dn-associated dendritic deterioration,
altered synapse organization, and mitochondrial dysfunction.
Furthermore, this phosphoproteomic study provides an
extensive repertoire of the iGluR phosphosites, together with
the respective predicted kinases. Importantly, although the
mechanistic studies remain elusive, the characterization of the
iGluR phosphopattern and the predicted associated kinases in
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the Ts65Dn hippocampi may help to identify novel therapeutic
targets for DS synaptopathy.
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